Skip to content

Study · Not a test of the peptide alone · 1986

1 result

Adrenal steroid responses to continuous intravenous adrenocorticotropin infusion compared to bolus injection in normal volunteers.

Munabi AK, Feuillan P, Staton RC, Rodbard D, Chrousos GP, Anderson RE, Strober MD, Loriaux DL, Cutler GB Jr

The Journal of clinical endocrinology and metabolism1 Oct 1986Cited by 8 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Cosyntropin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cosyntropin.

  1. 01HumanNot a test of Cosyntropin aloneRandomized controlled trialActivity measurement

    In normal volunteers, 250 micrograms cosyntropin produced no significant differences in steroid concentrations, increments, ratios, or areas above baseline between bolus injection and continuous 2-h intravenous infusion.

    In plain wordsIn normal volunteers, steroid responses did not differ significantly between cosyntropin bolus injection and continuous infusion.

    Outcome
    No significant changeAdrenal steroid response panel
    Study

    n = 17

    Comparator
    Continuous 2-h intravenous infusion
    Outcome group
    Adrenal Function · Endocrine and hormones

    Source sentences

    Summary
    The steroid concentrations and their increments, ratios, or areas above baseline did not differ significantly between the bolus injection and the continuous infusion.
    2 context sentences
    Summary · context
    We compared the adrenal steroid responses after synthetic ACTH-(1-24) (Cosyntropin) administration given by either continuous iv infusion or bolus injection in 11 normal women and 6 normal men.
    Summary · context
    Each subject received 250 micrograms Cosyntropin as a bolus iv injection on 1 occasion and as a continuous 2-h iv infusion on another occasion, in random order.

    In this study, Cosyntropin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cosyntropin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.